You are here

EDP-239

Novartis drops out of hep C race, punting a $440M Enanta pact

Fierce Biotech

Wed, 10/1/14 - 09:19 am

Enanta Pharmaceuticals

Enanta partners with Novartis to develop new drug to treat hepatitis C virus

Boston Globe, MA

Tue, 02/21/12 - 09:36 am